Literature DB >> 12815574

Endothelins and myocardial fibrosis.

Felix J A Ramires1, Vera L Nunes, Fabio Fernandes, Charles Mady, José A F Ramires.   

Abstract

BACKGROUND: Endothelins are associated with cardiac remodeling. These peptides are the most powerful vasoconstrictor described-whether this remodeling is a direct effect of this hormone or indirect response to a relative ischemia promoted by vasoconstrictor effect. We evaluated the role of endothelin upon myocardial fibrosis despite of its hemodynamic effects and the benefits of its antagonism. METHODS AND
RESULTS: We used 40 Wistar rats: control, sham operated, rats had undergone myocardial infarction (MI) and MI rats treated with SB209670 which is an ET(A)/ET(B) endothelin antagonist. We evaluated tail systolic blood pressure (BP) and left ventricular end diastolic pressure (LVED) before surgery, just after, and at the end of the study. Remodeling was studied based on interstitial collagen and MI size by an image system analysis. BP decreased in MI groups after surgery, but did not differ between treated and untreated animals. LVED had increased levels in MI groups after surgery and did not differ between them. However, ICVF had an increase in MI group but significantly less in MI+SB209670. MI size was similar in both groups.
CONCLUSIONS: Endothelin may have a pivotal role in the myocardial fibrosis by direct stimulation of collagen accumulation despite of its hemodynamic effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815574     DOI: 10.1054/jcaf.2003.26

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  4 in total

1.  Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease.

Authors:  Herbert B Tanowitz; Huan Huang; Linda A Jelicks; Madhulika Chandra; Maria L Loredo; Louis M Weiss; Stephen M Factor; Vitaliy Shtutin; Shankar Mukherjee; Richard N Kitsis; George J Christ; Murray Wittner; Jamshid Shirani; Yaz Y Kisanuki; Masashi Yanagisawa
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 2.  Endothelin in health and disease.

Authors:  Emina Nakas-Ićindić; Asija Zaciragić; Almira Hadzović; Nesina Avdagić
Journal:  Bosn J Basic Med Sci       Date:  2004-07       Impact factor: 3.363

3.  Synergistic growth inhibitory effects of the dual endothelin-1 receptor antagonist bosentan on pancreatic stellate and cancer cells.

Authors:  Brit Fitzner; Peter Brock; Stephanie-Anna Holzhüter; Horst Nizze; Gisela Sparmann; Jörg Emmrich; Stefan Liebe; Robert Jaster
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

4.  Impulse conduction and gap junctional remodelling by endothelin-1 in cultured neonatal rat ventricular myocytes.

Authors:  Y Reisner; G Meiry; N Zeevi-Levin; D Y Barac; I Reiter; Z Abassi; N Ziv; S Kostin; J Schaper; M R Rosen; O Binah
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.